A1FL34 Stock Overview
Through its subsidiaries, provides supplemental health and life insurance products. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 4/6 |
Aflac Incorporated Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$648.32 |
| 52 Week High | US$648.32 |
| 52 Week Low | US$378.51 |
| Beta | 0.96 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | 61.47% |
| 33 Year Change | 105.49% |
| 5 Year Change | n/a |
| Change since IPO | 205.68% |
Recent News & Updates
Recent updates
Shareholder Returns
| A1FL34 | BR Insurance | BR Market | |
|---|---|---|---|
| 7D | 0% | -1.4% | -0.06% |
| 1Y | 61.5% | 16.2% | -1.6% |
Return vs Industry: A1FL34 exceeded the BR Insurance industry which returned 16.2% over the past year.
Return vs Market: A1FL34 exceeded the BR Market which returned -1.6% over the past year.
Price Volatility
| A1FL34 volatility | |
|---|---|
| A1FL34 Average Weekly Movement | n/a |
| Insurance Industry Average Movement | 3.0% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in BR Market | 8.5% |
| 10% least volatile stocks in BR Market | 2.3% |
Stable Share Price: A1FL34's share price has been volatile over the past 3 months compared to the BR market.
Volatility Over Time: Insufficient data to determine A1FL34's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1955 | 12,785 | Dan Amos | www.aflac.com |
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Aflac Incorporated Fundamentals Summary
| A1FL34 fundamental statistics | |
|---|---|
| Market cap | R$358.43b |
| Earnings (TTM) | R$22.08b |
| Revenue (TTM) | R$100.28b |
16.2x
P/E Ratio3.6x
P/S RatioIs A1FL34 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A1FL34 income statement (TTM) | |
|---|---|
| Revenue | US$17.30b |
| Cost of Revenue | US$9.48b |
| Gross Profit | US$7.82b |
| Other Expenses | US$4.01b |
| Earnings | US$3.81b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 6.86 |
| Gross Margin | 45.20% |
| Net Profit Margin | 22.01% |
| Debt/Equity Ratio | 49.7% |
How did A1FL34 perform over the long term?
See historical performance and comparisonDividends
1.8%
Current Dividend Yield29%
Payout RatioDoes A1FL34 pay a reliable dividends?
See A1FL34 dividend history and benchmarks| Aflac dividend dates | |
|---|---|
| Ex Dividend Date | Nov 18 2024 |
| Dividend Pay Date | Dec 06 2024 |
| Days until Ex dividend | 1 day |
| Days until Dividend pay date | 19 days |
Does A1FL34 pay a reliable dividends?
See A1FL34 dividend history and benchmarks